Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other 2

Conditions

Polycystic Ovary Syndrome 4Obesity 2

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Cosyntropin × Clear all
NCT03905603 2023-11-03

SHK001

University of Virginia

Phase EARLY_PHASE1 Unknown
144 enrolled

Polycystic Ovary Syndrome

NCT01421797 2023-10-27

JCM022

University of Virginia

Phase NA Unknown
84 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT01422733 2018-07-19

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

NCT00989781 2018-06-04

Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

University of California, San Diego

Phase NA Completed
41 enrolled 8 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡